Dermatology Drugs Market Research Report: By Treatment, Drug, Prescription Mode, Therapy Area, Distribution Channel, End User - Global Industry Analysis and Growth Forecast to 2030

Due to the rise in the geriatric population, growing prevalence of dermatological diseases, increasing awareness about skin problems, soaring spending capability of the people, and huge pipeline of dermatological drugs, the global dermatology drugs market is expected to advance rapidly during the forecast period (2018-2023). The market is predicted to advance at the CAGR of 8.2% during the forecast period, from its recorded value of $21.5 billion in 2017, to reach $34.5 billion by 2023.

The increasing prevalence of skin diseases is one of the biggest factors boosting the growth of the dermatology drugs market. Trauma, environmental and genetic factors, and aging are some of the most significant factors causing skin diseases in millions of people across the globe. As per the observations of the World Health Organization (WHO), skin diseases are one of the most common forms of health disorders and they affect nearly 900 million people at a time, around the world.

With the increase in age, the proper functioning of the human skin starts to be lost, resulting in the occurrence of various skin diseases, thereby driving the progress of the dermatology drugs market. Moreover, with age, the body also starts experiencing several other problems, such as slow healing of wounds, higher sensitivity to ultraviolet (UV) radiation, greater vulnerability to infections, and reduction in subcutaneous fat. This increases the probability of various skin problems, thereby shooting up the demand for dermatological drugs.

Based on treatment, the dermatology drugs market is divided into multiple categories, namely retinoids, calcineurin inhibitors, hormonal therapy, topical corticosteroids, biologics, antihistamines, and others, wherein the others category includes antifungal, antibacterial, and antiviral agents and enzyme inhibitors. Amongst the different categories, topical corticosteroids had the largest share in the market, in terms of revenue, in 2017. This was primarily due to the rise in the demand for these drugs as a result of the growing prevalence of eczema across the world.

On the basis of geographical analysis, North America recorded the largest share in the dermatology drugs market, of 43.3%, in terms of revenue, in 2017. The key factors which contributed in the high demand for such therapeutics in the region was the rapidly rising awareness amongst the people about the newly developed and launched drugs and the high per capita income. Asia-Pacific (APAC) is predicted to register the fastest growth in the market during the forecast period.

Therefore, it can be concluded that the market, owing to the growing geriatric population across the world and increasing awareness amongst the masses regarding various dermatological drugs, is set to flourish in the coming years.

Chapter 1. Research Background

1.1 Research Objectives
1.2 Market Definition
1.3 Research Scope
1.3.1 Market Segmentation by Treatment
1.3.2 Market Segmentation by Drug
1.3.3 Market Segmentation by Prescription Mode
1.3.4 Market Segmentation by Therapy Area
1.3.5 Market Segmentation by Distribution Channel
1.3.6 Market Segmentation by End User
1.3.7 Market Segmentation by Region
1.3.8 Analysis Period
1.3.9 Market Data Reporting Unit
1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research
2.2 Primary Research
2.2.1 Breakdown of Primary Research Respondents
2.2.1.1 By region
2.2.1.2 By industry participant
2.2.1.3 By company type
2.3 Market Size Estimation
2.4 Data Triangulation
2.5 Currency Conversion Rates
2.6 Assumptions for the Study

Chapter 3. Executive Summary

Chapter 4. Introduction

4.1 Definition of Market Segments
4.1.1 By Treatment
4.1.1.1 Topical corticosteroids
4.1.1.2 Retinoids
4.1.1.3 Biologics
4.1.1.4 Calcineurin inhibitors
4.1.1.5 Antihistamines
4.1.1.6 Hormone therapy
4.1.1.7 Others
4.1.2 By Drug
4.1.2.1 Humira
4.1.2.2 Remicade
4.1.2.3 Otezla
4.1.2.4 Stelara
4.1.2.5 Enbrel
4.1.2.6 Cosentyx
4.1.2.7 Neoral
4.1.2.8 Taltz
4.1.2.9 Cubicin
4.1.2.10 Canesten
4.1.2.11 Zyvox
4.1.2.12 Dupixent
4.1.2.13 Protopic
4.1.2.14 Valtrex
4.1.2.15 Eucrisa
4.1.2.16 Others
4.1.3 By Prescription Mode
4.1.3.1 Prescription drugs
4.1.3.2 OTC drugs
4.1.4 By Therapeutic Area
4.1.4.1 Psoriasis
4.1.4.2 Atopic dermatitis
4.1.4.3 Acne
4.1.4.4 Rosacea
4.1.4.5 Skin cancer
4.1.4.6 Scar
4.1.4.7 Others
4.1.5 By Distribution Channel
4.1.5.1 Direct
4.1.5.2 Wholesale/retail
4.1.5.3 Online
4.1.6 By End User
4.1.6.1 Hospitals
4.1.6.2 Clinics
4.1.6.3 Cosmetic centers
4.1.6.4 At-home
4.1.6.5 Others
4.2 Market Dynamics
4.2.1 Trends
4.2.1.1 Product approvals
4.2.2 Drivers
4.2.2.1 Rising geriatric population
4.2.2.2 Increasing incidence of dermatological diseases
4.2.2.3 Growing awareness on skin diseases
4.2.2.4 Increasing personal care spending
4.2.2.5 Strong pipeline of dermatological drugs
4.2.2.6 Impact analysis of drivers on market forecast
4.2.3 Restraints
4.2.3.1 Patent expiry and generic drug development
4.2.3.2 Side-effects of certain classes of therapeutic drugs
4.2.3.3 Impact analysis of restraints on market forecast
4.2.4 Opportunities
4.2.4.1 Huge potential in emerging markets
4.3 Impact of COVID-19
4.4 Porter’s Five Forces Analysis

Chapter 5. Global Market Size and Forecast

5.1 Overview
5.2 By Treatment
5.3 By Drug
5.4 By Prescription Mode
5.5 By Therapy Area
5.5.1 Psoriasis Drugs Market, by Prescription Mode
5.5.2 Atopic Dermatitis Drugs Market, by Prescription Mode
5.5.3 Acne Drugs Market, by Prescription Mode
5.5.4 Rosacea Drugs Market, by Prescription Mode
5.5.5 Scar Drugs Market, by Prescription Mode
5.5.6 Skin Cancer Drugs Market, by Prescription Mode
5.6 By Distribution Channel
5.7 By End User
5.8 By Region

Chapter 6. North America Market Size and Forecast

6.1 Overview
6.2 By Treatment
6.3 By Prescription Mode
6.4 By Therapy Area
6.4.1 Psoriasis Drugs Market, by Prescription Mode
6.4.2 Atopic Dermatitis Drugs Market, by Prescription Mode
6.4.3 Acne Drugs Market, by Prescription Mode
6.4.4 Rosacea Drugs Market, by Prescription Mode
6.4.5 Scar Drugs Market, by Prescription Mode
6.4.6 Skin Cancer Drugs Market, by Prescription Mode
6.5 By Distribution Channel
6.6 By End User
6.7 By Country
6.7.1 U.S. Dermatology Drugs Market
6.7.1.1 By treatment
6.7.1.2 By distribution channel
6.7.2 Canada Dermatology Drugs Market
6.7.2.1 By treatment
6.7.2.2 By distribution channel

Chapter 7. Europe Market Size and Forecast

7.1 Overview
7.2 By Treatment
7.3 By Prescription Mode
7.4 By Therapy Area
7.4.1 Psoriasis Drugs Market, by Prescription Mode
7.4.2 Atopic Dermatitis Drugs Market, by Prescription Mode
7.4.3 Acne Drugs Market, by Prescription Mode
7.4.4 Rosacea Drugs Market, by Prescription Mode
7.4.5 Scar Drugs Market, by Prescription Mode
7.4.6 Skin Cancer Drugs Market, by Prescription Mode
7.5 By Distribution Channel
7.6 By End User
7.7 By Country
7.7.1 Germany Dermatology Drugs Market
7.7.1.1 By treatment
7.7.1.2 By distribution channel
7.7.2 France Dermatology Drugs Market
7.7.2.1 By treatment
7.7.2.2 By distribution channel
7.7.3 U.K. Dermatology Drugs Market
7.7.3.1 By treatment
7.7.3.2 By distribution channel
7.7.4 Italy Dermatology Drugs Market
7.7.4.1 By treatment
7.7.4.2 By distribution channel
7.7.5 Spain Dermatology Drugs Market
7.7.5.1 By treatment
7.7.5.2 By distribution channel

Chapter 8. APAC Market Size and Forecast

8.1 Overview
8.2 By Treatment
8.3 By Prescription Mode
8.4 By Therapy Area
8.4.1 Psoriasis Drugs Market, by Prescription Mode
8.4.2 Atopic Dermatitis Drugs Market, by Prescription Mode
8.4.3 Acne Drugs Market, by Prescription Mode
8.4.4 Rosacea Drugs Market, by Prescription Mode
8.4.5 Scar Drugs Market, by Prescription Mode
8.4.6 Skin Cancer Drugs Market, by Prescription Mode
8.5 By Distribution Channel
8.6 By End User
8.7 By Country
8.7.1 Japan Dermatology Drugs Market
8.7.1.1 By treatment
8.7.1.2 By distribution channel
8.7.2 China Dermatology Drugs Market
8.7.2.1 By treatment
8.7.2.2 By distribution channel
8.7.3 India Dermatology Drugs Market
8.7.3.1 By treatment
8.7.3.2 By distribution channel

Chapter 9. LATAM Market Size and Forecast

9.1 Overview
9.2 By Treatment
9.3 By Prescription Mode
9.4 By Therapy Area
9.4.1 Psoriasis Drugs Market, by Prescription Mode
9.4.2 Atopic Dermatitis Drugs Market, by Prescription Mode
9.4.3 Acne Dermatology Drugs Market, by Prescription Mode
9.4.4 Rosacea Drugs Market, by Prescription Mode
9.4.5 Scar Drugs Market, by Prescription Mode
9.4.6 Skin Cancer Drugs Market, by Prescription Mode
9.5 By Distribution Channel
9.6 By End User
9.7 By Country

Chapter 10. MEA Market Size and Forecast

10.1 Overview
10.2 By Treatment
10.3 By Prescription Mode
10.4 By Therapy Area
10.4.1 Psoriasis Drugs Market, by Prescription Mode
10.4.2 Atopic Dermatitis Drugs Market, by Prescription Mode
10.4.3 Acne Drugs Market, by Prescription Mode
10.4.4 Rosacea Drugs Market, by Prescription Mode
10.4.5 Scar Drugs Market, by Prescription Mode
10.4.6 Skin Cancer Drugs Market, by Prescription Mode
10.5 By Distribution Channel
10.6 By End User
10.7 By Country

Chapter 11. Competitive Landscape

11.1 Product Benchmarking of Key Players
11.2 Strategic Developments
11.2.1 Product Launches and Approvals
11.2.2 Acquisitions
11.2.3 Other Developments

Chapter 12. Company Profiles

12.1 Bausch Health Companies Inc.
12.1.1 Business Overview
12.1.2 Product and Service Offerings
12.1.3 Key Financial Summary
12.2 Novartis AG
12.2.1 Business Overview
12.2.2 Product and Service Offerings
12.2.3 Key Financial Summary
12.3 Pfizer Inc.
12.3.1 Business Overview
12.3.2 Product and Service Offerings
12.3.3 Key Financial Summary
12.4 Bristol-Myers Squibb Company
12.4.1 Business Overview
12.4.2 Product and Service Offerings
12.4.3 Key Financial Summary
12.5 Johnson & Johnson
12.5.1 Business Overview
12.5.2 Product and Service Offerings
12.5.3 Key Financial Summary
12.6 Merck & Co. Inc.
12.6.1 Business Overview
12.6.2 Product and Service Offerings
12.6.3 Key Financial Summary
12.7 Amgen Inc.
12.7.1 Business Overview
12.7.2 Product and Service Offerings
12.7.3 Key Financial Summary
12.8 AbbVie Inc.
12.8.1 Business Overview
12.8.2 Product and Service Offerings
12.8.3 Key Financial Summary
12.9 Eli Lilly and Company
12.9.1 Business Overview
12.9.2 Product and Service Offerings
12.9.3 Key Financial Summary
12.10 Galderma S.A.
12.10.1 Business Overview
12.10.2 Product and Service Offerings
12.11 GlaxoSmithKline plc
12.11.1 Business Overview
12.11.2 Product and Service Offerings
12.11.3 Key Financial Summary
12.12 Mylan N.V.
12.12.1 Business Overview
12.12.2 Product and Service Offerings
12.12.3 Key Financial Summary
12.13 LEO Pharma A/S
12.13.1 Business Overview
12.13.2 Product and Service Offerings
12.13.3 Key Financial Summary
12.14 Sanofi
12.14.1 Business Overview
12.14.2 Product and Service Offerings
12.14.3 Key Financial Summary

Chapter 13. Appendix

13.1 Abbreviations
13.2 Sources and References
13.3 Related Reports

List of Tables

Table 1 Analysis Period of The Study
Table 2 Pipeline Drugs For Treatment of Acne
Table 3 Pipeline Drugs For Treatment of Actinic Keratosis
Table 4 Drivers For The Market: Impact Analysis
Table 5 Patent Expiration of Dermatology Drugs
Table 6 Restraints For The Market: Impact Analysis
Table 7 Global Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 8 Global Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 9 Global Dermatology Drugs Market, By Drug, $M (2014-2019)
Table 10 Global Dermatology Drugs Market, By Drug, $M (2020-2030)
Table 11 Global Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 12 Global Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 13 Global Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 14 Global Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 15 Global Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 16 Global Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 17 Global Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 18 Global Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 19 Global Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 20 Global Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 21 Global Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 22 Global Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 23 Global Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 24 Global Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 25 Global Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 26 Global Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 27 Global Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 28 Global Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 29 Global Dermatology Drugs Market, By End User, $M (2014-2019)
Table 30 Global Dermatology Drugs Market, By End User, $M (2020-2030)
Table 31 Global Dermatology Drugs Market, By Region, $M (2014-2019)
Table 32 Global Dermatology Drugs Market, By Region, $M (2020-2030)
Table 33 North America Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 34 North America Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 35 North America Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 36 North America Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 37 North America Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 38 North America Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 39 North America Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 40 North America Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 41 North America Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 42 North America Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 43 North America Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 44 North America Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 45 North America Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 46 North America Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 47 North America Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 48 North America Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 49 North America Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 50 North America Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 51 North America Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 52 North America Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 53 North America Dermatology Drugs Market, By End User, $M (2014-2019)
Table 54 North America Dermatology Drugs Market, By End User, $M (2020-2030)
Table 55 North America Dermatology Drugs Market, By Country, $M (2014-2019)
Table 56 North America Dermatology Drugs Market, By Country, $M (2020-2030)
Table 57 U.S. Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 58 U.S. Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 59 U.S. Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 60 U.S. Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 61 Canada Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 62 Canada Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 63 Canada Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 64 Canada Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 65 Europe Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 66 Europe Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 67 Europe Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 68 Europe Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 69 Europe Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 70 Europe Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 71 Europe Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 72 Europe Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 73 Europe Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 74 Europe Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 75 Europe Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 76 Europe Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 77 Europe Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 78 Europe Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 79 Europe Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 80 Europe Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 81 Europe Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 82 Europe Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 83 Europe Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 84 Europe Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 85 Europe Dermatology Drugs Market, By End User, $M (2014-2019)
Table 86 Europe Dermatology Drugs Market, By End User, $M (2020-2030)
Table 87 Europe Dermatology Drugs Market, By Country, $M (2014-2019)
Table 88 Europe Dermatology Drugs Market, By Country, $M (2020-2030)
Table 89 Germany Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 90 Germany Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 91 Germany Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 92 Germany Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 93 France Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 94 France Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 95 France Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 96 France Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 97 U.K. Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 98 U.K. Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 99 U.K. Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 100 U.K. Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 101 Italy Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 102 Italy Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 103 Italy Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 104 Italy Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 105 Spain Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 106 Spain Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 107 Spain Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 108 Spain Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 109 Apac Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 110 Apac Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 111 Apac Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 112 Apac Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 113 Apac Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 114 Apac Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 115 Apac Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 116 Apac Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 117 Apac Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 118 Apac Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 119 Apac Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 120 Apac Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 121 Apac Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 122 Apac Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 123 Apac Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 124 Apac Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 125 Apac Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 126 Apac Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 127 Apac Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 128 Apac Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 129 Apac Dermatology Drugs Market, By End User, $M (2014-2019)
Table 130 Apac Dermatology Drugs Market, By End User, $M (2020-2030)
Table 131 Apac Dermatology Drugs Market, By Country, $M (2014-2019)
Table 132 Apac Dermatology Drugs Market, By Country, $M (2020-2030)
Table 133 Japan Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 134 Japan Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 135 Japan Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 136 Japan Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 137 China Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 138 China Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 139 China Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 140 China Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 141 India Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 142 India Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 143 India Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 144 India Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 145 Latam Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 146 Latam Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 147 Latam Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 148 Latam Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 149 Latam Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 150 Latam Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 151 Latam Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 152 Latam Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 153 Latam Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 154 Latam Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 155 Latam Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 156 Latam Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 157 Latam Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 158 Latam Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 159 Latam Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 160 Latam Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 161 Latam Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 162 Latam Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 163 Latam Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 164 Latam Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 165 Latam Dermatology Drugs Market, By End User, $M (2014-2019)
Table 166 Latam Dermatology Drugs Market, By End User, $M (2020-2030)
Table 167 Latam Dermatology Drugs Market, By Country, $M (2014-2019)
Table 168 Latam Dermatology Drugs Market, By Country, $M (2020-2030)
Table 169 Mea Dermatology Drugs Market, By Treatment, $M (2014-2019)
Table 170 Mea Dermatology Drugs Market, By Treatment, $M (2020-2030)
Table 171 Mea Dermatology Drugs Market, By Prescription Mode, $M (2014-2019)
Table 172 Mea Dermatology Drugs Market, By Prescription Mode, $M (2020-2030)
Table 173 Mea Dermatology Drugs Market, By Therapy Area, $M (2014-2019)
Table 174 Mea Dermatology Drugs Market, By Therapy Area, $M (2020-2030)
Table 175 Mea Psoriasis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 176 Mea Psoriasis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 177 Mea Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2014-2019)
Table 178 Mea Atopic Dermatitis Drugs Market, By Prescription Mode, $M (2020-2030)
Table 179 Mea Acne Drugs Market, By Prescription Mode, $M (2014-2019)
Table 180 Mea Acne Drugs Market, By Prescription Mode, $M (2020-2030)
Table 181 Mea Rosacea Drugs Market, By Prescription Mode, $M (2014-2019)
Table 182 Mea Rosacea Drugs Market, By Prescription Mode, $M (2020-2030)
Table 183 Mea Scar Drugs Market, By Prescription Mode, $M (2014-2019)
Table 184 Mea Scar Drugs Market, By Prescription Mode, $M (2020-2030)
Table 185 Mea Skin Cancer Drugs Market, By Prescription Mode, $M (2014-2019)
Table 186 Mea Skin Cancer Drugs Market, By Prescription Mode, $M (2020-2030)
Table 187 Mea Dermatology Drugs Market, By Distribution Channel, $M (2014-2019)
Table 188 Mea Dermatology Drugs Market, By Distribution Channel, $M (2020-2030)
Table 189 Mea Dermatology Drugs Market, By End User, $M (2014-2019)
Table 190 Mea Dermatology Drugs Market, By End User, $M (2020-2030)
Table 191 Mea Dermatology Drugs Market, By Country, $M (2014-2019)
Table 192 Mea Dermatology Drugs Market, By Country, $M (2020-2030)
Table 193 Bausch Health Companies Inc. - At A Glance
Table 194 Bausch Health Companies Inc. - Key Financial Summary
Table 195 Novartis Ag - At A Glance
Table 196 Novartis Ag - Key Financial Summary
Table 197 Pfizer Inc. - At A Glance
Table 198 Pfizer Inc. - Key Financial Summary
Table 199 Bristol-Myers Squibb Company - At A Glance
Table 200 Bristol-Myers Squibb Company - Key Financial Summary
Table 201 Johnson & Johnson - At A Glance
Table 202 Johnson & Johnson - Key Financial Summary
Table 203 Merck & Co. Inc. - At A Glance
Table 204 Merck & Co. Inc. - Key Financial Summary
Table 205 Amgen Inc. - At A Glance
Table 206 Amgen Inc. - Key Financial Summary
Table 207 Abbvie Inc. - At A Glance
Table 208 Abbvie Inc. - Key Financial Summary
Table 209 Eli Lilly And Company - At A Glance
Table 210 Eli Lilly And Company - Key Financial Summary
Table 211 Galderma S.A. - At A Glance
Table 212 Glaxosmithkline Plc - At A Glance
Table 213 Glaxosmithkline Plc - Key Financial Summary
Table 214 Mylan N.V. - At A Glance
Table 215 Mylan N.V. - Key Financial Summary
Table 216 Leo Pharma A/S - At A Glance
Table 217 Leo Pharma A/S - Key Financial Summary
Table 218 Sanofi - At A Glance
Table 219 Sanofi - Key Financial Summary

Companies Mentioned

Bausch Health Companies Inc.
Novartis AG
Pfizer Inc.
Bristol-Myers Squibb Company
Johnson & Johnson
Merck & Co. Inc.
Amgen Inc.
AbbVie Inc.
Eli Lilly and Company
Galderma S.A.
GlaxoSmithKline plc
Mylan N.V.
LEO Pharma A/S
Sanofi

Methodology

LOADING...

Table of Contents

Companies Mentioned

Methodology

Related Topics

Related Reports

Dermatological Therapeutics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Atopic Dermatitis Market, By Drug Class, By Type of Administration, By Prescription Type, and By Geography - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028

Dermatological OTC Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Global Dermatological Drug Market - Forecasts from 2022 to 2027

Global Atopic Dermatitis Drugs Market Size, Share & Industry Trends Analysis Report By Route of Administration, By Class (Biologics, Calcineurin Inhibitors, Corticosteroids, PDE4 Inhibitors), By Regional Outlook and Forecast, 2022 - 2028